No Prescription |
 |
 | ||
|
EURYTHMIC Cordarone |
|
| ||
No Prescription » Prescription Drugs 7 » EURYTHMIC Cordarone Amiodarone is used to treat and prevent certain types of ventricular arrhythmias (abnormal heart rhythm). Amiodarone is in a class of medications called antiarrhythmics. It works by relaxing overactive heart muscles.Amiodarone comes as a tablet to take by mouth. It is usually taken once or twice a day. Your doctor will tell you to take amiodarone with or without food; be sure to take it the same way each time. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take amiodarone exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.Amiodarone controls arrhythmias but does not cure them. Continue to take amiodarone even if you feel well. Do not stop taking amiodarone without talking to your doctor. If you suddenly stop taking amiodarone your condition may get worse. Buy EURYTHMIC Cordarone and other Prescription Drugs 7 products online at Medstore. Buy Online at Medstore - Click Here!
About EURYTHMIC Cordarone: Product Type: Prescription Drugs 7 EURYTHMIC ( Cordarone Pacerone Generic Amiodarone ) EURYTHMIC (Cordarone Pacerone Generic Amiodarone) Cordarone Pacerone Generic Amiodarone 100mg Tabs 200mg Tabs 100 (10 x10) Cordarone Pacerone Generic Amiodarone EURYTHMIC
View more Prescription Drugs 7 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
